October 2014


In this Supplement

New Standards in Angioplasty

Expert discussion and challenging case reviews show that we may be on the verge of a major transformation in angioplasty-centric therapy for lower extremity interventions.



Download a PDF of this supplement

Leaving Options Open in Lower Extremity Intervention

Experienced operators share what you need to know before adopting the Chocolate® PTA Balloon Catheter as a first-line therapy into your practice.

With Craig Walker, MD; Mehdi H. Shishehbor, DO, MPH, PhD; Robert Beasley, MS, MD; J.A. Mustapha, MD; and Syed Hussain, MD

The Chocolate® Percutaneous Transluminal Angioplasty Balloon Catheter

Excerpt from Charisse Ward, MD, and Carlos Mena-Hurtado, MD

SFA and BTK Interventions With the Chocolate® PTA Balloon Catheter

This device allows operators to achieve excellent results with low rates of dissection, as demonstrated in these cases of high-grade stenosis.

By Brandon Olivieri, MD, and Robert Beasley, MS, MD

Popliteal PTA and Transpedal Reconstruction Using the Chocolate® PTA Balloon

A case report detailing treatment of popliteal disease and diabetic foot ulcer.

By Mehdi H. Shishehbor, DO, MPH, PhD

Covering Every Case: The SABER™ PTA Dilatation Catheter

A discussion with J.A. Mustapha, MD, and Craig Walker, MD, on how the SABER™ Catheter provides an important option for lower extremity endovascular therapy.

With J.A. Mustapha, MD, and Craig Walker, MD

Lower Extremity CTO Crossing With the SABER™ Catheter

Two case reports showing initial experience with the SABER™ Catheter for the treatment of chronic total occlusions.

By J.A. Mustapha, MD

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.